This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
Invest in both McDonald's stock and Eli Lilly.
Literally was talking to a friend on what’s the indirect buy on these drugs. Said the exact same thing Pepsi and McDonald’s.
More options
Context Copy link
Wait, no. The point of these drugs is that they kill your appetite. McDonald's is going to get wrecked.
More options
Context Copy link
More options
Context Copy link